COMMUNIQUÉS West-GlobeNewswire

SafeSpace Global Appoints former Amazon, Google and YouTube Executive as Chief Operating Officer to Accelerate Next Phase of AI-Powered Growth
13/10/2026
Technology Industry Veteran Prashant “Shaun” Kancherla Brings More than a Decade of Global Leadership and a Track Record of Delivering Operating Efficiencies KNOXVILLE, Tenn., Oct. 13, 2026 (GLOBE NEWSWIRE) -- SafeSpace [...]
Daré Bioscience Launches “CEO Corner” Video Series to Highlight the Company’s Pipeline of Women’s Health Innovations, Corporate Strategy and Opportunities
13/10/2026
New video series featuring Founder, President and CEO Sabrina Martucci Johnson will provide investors with insights into Daré Bioscience’s growing commercial portfolio, clinical pipeline and strategic priorities Access [...]
ProText Mobility Chairman Confirms 831.3 Million Common Shares in SEC Filing — Chairman and CEO Reaffirm Zero Preferred Conversions, Unified Management Philosophy and Shareholder Solidarity
13/10/2026
Guided by Ubuntu — “I Am Because You Are” — Chairman Dr. Ahmed Jamaloodeen reinforces his substantial personal investment, long-term ownership commitment and shared vision with TXTM shareholders as the Company advances [...]
Acentra Health’s Chief Health and Informatics Officer Ryan Bosch, MD, FACP Named Fellow of the American College of Health Data Management
13/10/2026
Recognition honors Dr. Bosch’s leadership in population health, clinical informatics, and healthcare innovation MCLEAN, Va., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Acentra Health , a technology and health solutions company [...]
Giraffe Bio raises $6.4M Seed to scale next-generation reagents for copper mining
13/10/2026
Funding will accelerate manufacturing scale-up and industrial validation of drop-in biochemical flotation reagents designed to help miners recover more copper from increasingly complex ores BUENOS AIRES, Argentina and [...]
Stride Autism Centers Expands Early Intervention ABA Access with New Chicago Location
13/10/2026
Avondale–Logan Square center now accepting children ages 2–6 for individualized, center-based ABA therapy CHICAGO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Stride Autism Centers, a leading provider of Applied Behavior Analysis [...]
Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics
13/10/2026
Acquisition of Velaris and concurrent oversubscribed $350 million private placement positions the Company to deliver multiple proof-of-concept datasets in pulmonary arterial hypertension Velaris Therapeutics, the ninth [...]
Johns Hopkins Health Plans Named Corporate Champion by The Tree House Child Advocacy Center
13/10/2026
Recognition Honors Support for Critical Medical Services for Children in Montgomery County HANOVER, Md., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Johns Hopkins Health Plans has been named a Corporate Champion by The Tree House [...]
Sironax Advances Enrollment in Phase 2 FORGE-LM Obesity Trial of NAMPT Activator SIR4156
13/10/2026
Evaluating first-in-class asset to potentially address current obesity treatment deficiencies by promoting weight loss and preserving lean body mass WALTHAM, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Sironax, a global [...]
Opus Genetics to Present at the Chardan Annual Healthcare Conference
13/10/2026
RESEARCH TRIANGLE PARK, N.C., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore [...]
Visara Expands Ophthalmology Pipeline with Exclusive License for Investigational Nerve Growth Factor Therapy for Neurotrophic Keratitis
13/10/2026
Visara secures exclusive worldwide rights, excluding Greater China, from Wuhan Hiteck Biological Pharma to develop and commercialize HT006.2.2 Visara plans to develop HT006.2.2 as VIS-102, its second clinical-stage [...]
Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting
13/10/2026
Post-hoc Phase 2 data show greater bone mineral density (BMD) gains and anabolic effect with EB613 in postmenopausal women with baseline T-scores of ≤-2.5 (osteoporosis) versus T-scores of >-2.5 (osteopenia) These [...]
ZoomRx Launches Marketing Asset Testing (MAT) on Sagan Agents, Bringing Continuous, Channel-Specific Asset Testing to Pharma Brand Teams
13/10/2026
A new AI-powered application replaces the yearly messaging or concept testing study with cost-effective, iterative tests that optimize every marketing asset using synthetic and real HCPs, delivering results in days [...]
VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress
13/10/2026
In vivo data confirm activation of prodrug payload inside tumor cells following systemic administration of BiTAC-ADC molecules leading to potent anti-tumor activity ZURICH, SWITZERLAND – October 13, 2026 -- VERAXA [...]
5 Questions People Ask When Every Weight Loss Approach Has Failed
13/10/2026
Trilivy's™ mission is lifelong transformation through metabolic science and human connection Baltimore, MD, Oct. 13, 2026 (GLOBE NEWSWIRE) -- When every weight loss approach has failed , individuals wonder what went [...]
Aclarion to Present at the 20th Annual LD Micro Main Event
13/10/2026
BROOMFIELD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Aclarion (NASDAQ: ACON) announced today that it will participate in the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard [...]
Ever After Foods and Roslin Technologies Achieve Major Leap in Cultivated Meat Productivity
13/10/2026
Collaboration Demonstrates Substantially Higher Protein and Biomanufacturing Productivity While Producing Structured Cultivated Tissue HAIFA, Israel and EDINBURGH, Scotland, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Ever After [...]
Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer
13/10/2026
Combination cohorts are part of Prelude’s Phase 1 trial evaluating PRT13722 in patients with HR+/HER2- breast cancer, on track to initiate enrollment in the fourth quarter of 2026 The collaboration is underpinned by pre [...]
Mammogen Appoints Diagnostics Industry Leader, Dr. Robert S. Epstein, to Board of Directors
13/10/2026
Accomplished diagnostics and precision medicine leader brings decades of experience shaping the scientific, commercial and market success of category-defining companies across genomics, oncology and women's health [...]

Pages